Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 965-52-6 | Product Number: N1181
Nifuroxazide
×
![]()
×
Purity: >98.0%(T)
Synonyms:
- Bacifurane
- 4-Hydroxy-N'-[(5-nitrofuran-2-yl)methylene]benzohydrazide
- (5-Nitro-2-furfurylidene)(4-hydroxybenzoyl)hydrazine
Product Documents:
| Size | Unit Price | Belgium | Japan* |
|---|---|---|---|
| 100MG |
€20.00
|
Contact Us | 26 |
| 500MG |
€63.00
|
3 | 23 |
| 5G |
€204.00
|
1 | 34 |
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | N1181 |
| Purity / Analysis Method | >98.0%(T) |
| Molecular Formula / Molecular Weight | C__1__2H__9N__3O__5 = 275.22 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| Packaging and Container | 500MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 965-52-6 |
| Reaxys Registry Number | 4264976 |
| PubChem Substance ID | 468592501 |
| Merck Index (14) | 6535 |
| MDL Number | MFCD00079482 |
Specifications
| Appearance | White to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 257 °C(dec.) |
GHS
Related Laws:
| EC Number | 213-522-0 |
| RTECS# | DH2528300 |
Transport Information:
| HS Number | 2941900000 |
Application
Quorum sensing research
Nifuroxazide showed inhibition of quorum sensing-regulated gene expression and related phenotypes in Pseudomonas aeruginosa in a dose-dependent manner. 1)
References
- 1) Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors
Application
Nifuroxazide: An Antibacterial Agent with STAT3 Inhibitory Activity
Nifuroxazide is a broad-spectrum antibacterial agent that has been used for the treatment of infectious diarrhea since 1960’s.1) In 2008, it was discovered that nifuroxazide is a potent inhibitor of the transcription factor STAT3.2) Since then, the potential of nifuroxazide as an anticancer agent has been investigated.3) (The product is for research purpose only.)
References
- 1) In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice
- 2) Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- 3) Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment (a review)
- 4) Determination of nifuroxazide and drotaverine hydrochloride in pharmaceutical preparations by three independent analytical methods
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.